Author: Leah Kosyakovsky

HeLP: Behavioral interventions improve cardiac rehabilitation attendance among recently hospitalized patients with lower SES
ACC 2024, News

HeLP: Behavioral interventions improve cardiac rehabilitation attendance among recently hospitalized patients with lower SES

Key Points: Low-SES patients are less likely to attend CR following hospitalization for a major cardiovascular event and are more likely to be readmitted compared... Read more.
ACC 2024, News

MINT subgroup analysis: Among patients with acute MI and anemia, a restrictive transfusion strategy was associated with higher rates of death and MI at 30 days

Key Points: The MINT trial found that among patients with acute MI and anemia, those randomized to a liberal transfusion strategy had lower rates death or MI at... Read more.
Routine Assessment of Patient-Reported Health Status in Academic Clinics Did Not Improve Patient-Reported Health-Status: The PRO-HF Trial
ACC 2024, News

Routine Assessment of Patient-Reported Health Status in Academic Clinics Did Not Improve Patient-Reported Health-Status: The PRO-HF Trial

Key Points: The latest AHA/ACC Heart Failure (HF) guidelines recommend routine assessment of patient-reported health status, but no randomized trials have analyzed... Read more.
Advancing Acute MI Care in Densely Populated LMICs: Innovative Standalone Chest Pain Units for Expedited Triage and Timely Management – A Role Model for Global Healthcare Systems
ACC 2024, News

Advancing Acute MI Care in Densely Populated LMICs: Innovative Standalone Chest Pain Units for Expedited Triage and Timely Management – A Role Model for Global Healthcare Systems

Key Points:  The burden of coronary artery disease (CAD) is high in South Asia, but challenges are present with time-sensitive cardiac care, as evidenced within... Read more.
ACC 2024, News

Simultaneous Team-Based Remote Education and Medication Titration Increases Diabetes Medication Prescription Compared to a Sequential Approach: The Diabetes Remote Intervention to ImproVe Use of Evidence-based Medications (DRIVE) Study

Key Points:  Despite demonstrated effectiveness of many SGLT2-inhibitors and GLP-1 agonists at improving both cardiovascular (CV) and kidney outcomes, utilization... Read more.
ULTIMATE-DAPT: De-escalating to ticagrelor alone after 1 month reduced bleeding without an increase in ischemic events compared to continuous DAPT through 1 year
ACC 2024, News

ULTIMATE-DAPT: De-escalating to ticagrelor alone after 1 month reduced bleeding without an increase in ischemic events compared to continuous DAPT through 1 year

Key Points: The optimal time to de-escalate from DAPT to SAPT following PCI with modern DES after ACS is uncertain. The ULTIMATE-DAPT study found that transitioning... Read more.
LIBerate-HR Trial: Lerodalcibep, A Small-Binding Protein Based PCSK9 Inhibitor Administered Monthly Significantly Lowered LDL-C
ACC 2024, News

LIBerate-HR Trial: Lerodalcibep, A Small-Binding Protein Based PCSK9 Inhibitor Administered Monthly Significantly Lowered LDL-C

Key Points  – Newer cholesterol guidelines advise lower target values for LDL-C for high-risk patients, yet many patients do not reach this goal on statin... Read more.